Trial intelligence / Profile preview

Intrathecal levobupivacaine versus bupivacaine dose-response study for elective caesarean delivery

ChiCTR-TRC-12002923Phase 4Completed

Sponsor
The Chinese University of Hong Kong
Start
May 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levobupivacaine and bupivacaine (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Successful response. Started May 2002; status: completed.

02

Drugs

levobupivacainebupivacaine

Beyond the preview

Go deeper on ChiCTR-TRC-12002923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call